A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on parkinson disease risk: Time-since-cessation modifies the effect of tobacco smoking

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Van Der Mark, Marianne ^a   Nijssen, Peter C G ^b   Vlaanderen, Jelle ^a   Huss, Anke ^a   Mulleners, Wim M ^c   Sas, Antonetta M G ^d   Van Laar, Teus ^e   Kromhout, Hans ^a   Vermeulen, Roel ^a,f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b CPRLab   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d Vlietland Hospital   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COFFEE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COFFEE; COFFEE CONSUMPTION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PARKINSON DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SMOKING HABIT; CASE CONTROL STUDY; DRINKING BEHAVIOR; SMOKING; TOBACCO;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; COFFEE; HUMANS; PARKINSON DISEASE; SMOKING; SMOKING CESSATION; TOBACCO;

EID: 84899740082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095297     Document Type: Article

References (22)

1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of parkinson's disease: A review of the evidence. Eur J Epidemiol 26 Suppl 1: S1-58.
2. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of parkinson's disease. Ann Neurol 52: 276-284. (Pubitemid 35001493)
3. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, et al. (2007) Pooled analysis of tobacco use and risk of parkinson disease. Arch Neurol 64: 990-997. (Pubitemid 47047999)
4. Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernandez-Crehuet Navajas R (2004) Smoking and parkinson's disease: Systematic review of prospective studies. Mov Disord 19: 614-621. (Pubitemid 39173013)
5. Chen H, Huang X, Guo X, Mailman RB, Park Y, et al. (2010) Smoking duration, intensity, and risk of parkinson disease. Neurology 74: 878-884.
6. Thacker EL, O'Reilly EJ, Weisskopf MG, Chen H, Schwarzschild MA, et al. (2007) Temporal relationship between cigarette smoking and risk of parkinson disease. Neurology 68: 764-768. (Pubitemid 46667902)
7. Lubin JH, Caporaso NE (2006) Cigarette smoking and lung cancer: Modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 15: 517-523.
8. Vlaanderen J, Portengen L, Schuz J, Olsson A, Pesch B, et al. (2014) Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: A flexible method applied to cigarette smoking and lung cancer in the SYNERGY study. Am J Epidemiol 179: 290-298.
9. Oostenbrink JB, Rutten FF (2006) Cost assessment and price setting of inpatient care in the netherlands. the DBC case-mix system. Health Care Manag Sci 9: 287-294. (Pubitemid 44198214)
10. Rothman KJ, Greenland S, Lash TL (2008) Case-Control Studies. In: Modern Epidemiology: Lippincott Williams & Wilkins. pp. 111-127.
11. Quik M, O'Leary K, Tanner CM (2008) Nicotine and parkinson's disease: Implications for therapy. Mov Disord 23: 1641-1652.
12. Quik M, Perez XA, Bordia T (2012) Nicotine as a potential neuroprotective agent for parkinson's disease. Mov Disord 27: 947-957.
13. Dagher A, Robbins TW (2009) Personality, addiction, dopamine: Insights from parkinson's disease. Neuron 61: 502-510.
14. Menza M (2000) The personality associated with parkinson's disease. Curr Psychiatry Rep 2: 421-426.
15. Ishihara L, Brayne C (2006) What is the evidence for a premorbid parkinsonian personality: A systematic review. Mov Disord 21: 1066-1072. (Pubitemid 44336588)
16. Savica R, Rocca WA, Ahlskog JE (2010) When does parkinson disease start? Arch Neurol 67: 798-801.
17. Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, et al. (2002) Smoking and parkinson's disease in twins. Neurology 58: 581-588. (Pubitemid 34164940)
18. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL (2005) Risk and protective factors for parkinson's disease: A study in swedish twins. Ann Neurol 57: 27-33. (Pubitemid 40053312)
19. Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010) Caffeine exposure and the risk of parkinson's disease: A systematic review and meta-analysis of observational studies. J Alzheimers Dis 20 Suppl 1: S221-38.
20. Liu R, Guo X, Park Y, Huang X, Sinha R, et al. (2012) Caffeine intake, smoking, and risk of parkinson disease in men and women. Am J Epidemiol 175: 1200-1207.
21. Jenner P, Mori A, Hauser R, Morelli M, Fredholm BB, et al. (2009) Adenosine, adenosine A 2A antagonists, and parkinson's disease. Parkinsonism Relat Disord 15: 406-413.
22. Ishihara L, Brayne C (2005) A systematic review of nutritional risk factors of parkinson's disease. Nutr Res Rev 18: 259-282. (Pubitemid 43132207)